Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Astria Therapeutics, Inc. (ATXS) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/21/2022 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
06/21/2022 4/A BATE KENNETH (Director) has filed a Form 4 on Astria Therapeutics, Inc.
Txns: Granted 8,333 options to buy @ $0
06/21/2022 4/A Violin Jonathan (Director) has filed a Form 4 on Astria Therapeutics, Inc.
Txns: Granted 8,333 options to buy @ $0
06/21/2022 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
06/21/2022 4/A Cole Hugh M (Director) has filed a Form 4 on Astria Therapeutics, Inc.
Txns: Granted 8,333 options to buy @ $0
06/21/2022 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
06/21/2022 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
01/04/2019 4/A LAPOINTE ANTHONY GREGG (Director) has filed a Form 4 on CATABASIS PHARMACEUTICALS INC
Txns: Granted 2,800 options to buy @ $0
09/13/2016 4/A Cunnane Deirdre A. (SVP, General Counsel) has filed a Form 4 on CATABASIS PHARMACEUTICALS INC
09/13/2016 4/A Modi Rick (Chief Business Officer) has filed a Form 4 on CATABASIS PHARMACEUTICALS INC
09/13/2016 4/A Donovan Joanne M. (CMO; SVP Clinical Development) has filed a Form 4 on CATABASIS PHARMACEUTICALS INC
09/13/2016 4/A Milne Jill C. (CEO and President) has filed a Form 4 on CATABASIS PHARMACEUTICALS INC

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy